Monoclonal CGRP- (R) antibodies for the prevention of migraine
A new era in migraine prophylaxis has begun with the launch of antibodies blocking the Calcitonin-Gene Related Peptide (CGRP) pathway. These substances act across the entire frequency spectrum of migraine and have a tolerability superior to any other class of migraine preventatives based on our clin...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Whitehouse Publishing
2023-03-01
|
Series: | Advances in Clinical Neuroscience & Rehabilitation |
Online Access: | https://acnr.co.uk/articles/monoclonal-cgrp-r-antibodies-for-the-prevention-of-migraine/ |